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Summary.-A study has been made of the natural history of metastasis of a
spontaneous murine squamous carcinoma implanted into syngeneic recipients-a
situation where biologically different tumours and variable " host resistance " are
not complicating issues. The time distribution of deaths from metastatic disease
was incompatible with a log-normal distribution but was accurately described by
an exponential pattern of survival following an initial lag. While the average life
of doomed mice correlated with predictions based on growth rates, there was a wide
range of survival times indicating random influences on the evolution of metastatic
disease.
Insofar as tumours which grew to 20 mm3 or less in 5 days after tumour cell
injection failed to initiate metastases, while tumours which reached a size of 120 mm3
or greater (irrespective of duration) produced metastases in 38/39 mice, tumour
size was a prognostic index. However, within the size range 33-150 mm3 the corre-
lation between metastatic risk and size was not statistically significant. No corre-
lation between metastatic risk and duration of tumour growth from 6 to 29 days
was observed. Two integral functions of tumour size and duration were tested but
neither gave a better correlation with metastatic risk than did size alone.
BASIC to the understanding ofany can-
cer, and especially to assessments of the
value of treatment, is a knowledge of the
natural history of its growth and metas-
tasis. For obvious ethical reasons this
iniformation cannot be obtained for most
lhuman cancers. This paper describes the
natural history of a spontaneously arising,
syngeneically transplanted murine
squamous carcinoma.
The presentation is in two parts:
Section A deals with the mathematical
description of the distribution in time of
deaths from metastatic disease. The time
course ofthe evolution ofmetastases is also
considered in relation to the growth rate
of primary tumour implants. Section B
is a study of the possible prognostic
significance of the duration of primary
tumour growth and the size attained before
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locally curative treatment on the develop-
ment of metastases.
AIATERIALS AND METHODS
The experimental system, consisting of a
spontaneously arising syngeneically trans-
planted murine squamous carcinoma, has
been described in detail in the preceding
paper (Peters, 1975). A series ofexperiments
was there reported which tested the influence
of various diagnostic and therapeutic pro-
cedures applied to the primary tumour
implant on the subsequent development of
metastases. In these experiments, only 3
procedures were found to alter significantly
the metastatic behaviour of the tumour:
pre-operative irradiation (2000 rad 24 h before
excision) and treatment with ICRF 159;
both produced significantly lower incidences
ofmetastases, whereas local radiation therapy
sufficient to cause complete tumour regres-
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sion but insufficient to achieve long-term
local cure resulted in an increased incidence
of metastases. To examine the natural
history of the development of metastases in
this system, the 3 groups indicated above
were excluded but otherwise all the experi-
mental animals from that series of experi-
ments have been used in the present analysis.
In addition, a small control series from
experiments carried out in collaboration
with Dr W. Boggust of St Luke's Hospital,
Dublin, to test for a possible anti-metastat,ic
effect to o-phenanthroline (unpublished) h-as
been included. This resulted in a total of
306 mice available for analysis, of which 230
succumbed to metastatic disease.
Two supplementary experiments are also
reported in this paper: one to define a tumour
growth curve and the other to establislh the
minimum thresholdoftumourgrowth required
for the establishment of metastases. Details
of these 2 experiments are given with the
results.
EXPERIMIENTS AND RESULTS
Section A
1. Overall survival of mice with locally
cutred primary implants
(i) The log-normal model (Boag, 1948).
--The survival times afterprimarytherapy
of 230 mice which died of metastatic
disease are plotted in Fig. 1(a) on a
logarithmic time scale. The distribution
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is ralther skewNed to the right, eveni on a,
log scale, and the data are not well
described by a log-normal distribution
(X2 20 5; d.f.4; P < 0 005). The Pear-
sonian index of skewness* is + 0 536
whereas for a symmetrical distribution it
should be 0, and this difference is signifi-
cant at the O/0 level.
(ii) The exponential mnodel (Berkson aind
Gage, 1952; Haybittle, 1959). Mortality
of mice from the 15th day onward is well
described by an exponential survival
curve with an attritioni colnstant o-f
70600/,/day, intercepting the 100o/ sur-
vival level at 13-5 days (x2 = 4- X2;
d.f.4; P w C 3). No mouse died before
the 12th day after treatment and in the
range 12-15 days, the survival curve has
a small " shoulder " (Fig. I(b)). It should
be noted that the data strongly reject an
exponential curve constrained to begin at
zero time, though this is the way the
exponential model is usually applied to
clinical data. According to the exponen-
tial model, doomed mice had a " half-
* This is calculate(d as /53/03 when jI.t is the thir(d
moment of the (listributionl and a is the standardl
deviation. Its standlard error is
/
(o 2)(n
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( -- 2) (n jr- 1) (n + 3)
wherao is the ntumber of obseivationIs.
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Fio(.. 1(a). Distribution oIn a log-time scale of deaths from metastatic (lisease
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FIG. 1(b).-Number of survivors from 230
mice doomed to die of metastatic disease
as a function of time after primary treat-
ment indicating an exponential survival
pattern from 15 days onwards.
2. Determination of a tumour gro?vth.
curve
Sixteen mice were injected intra-
dermally with 1.1 x 105 living tumour
cells. Tumours grew as disc shaped
plaques which were regarded as flattened
cylinders for relative volume calculations.
Measurements of 2 diameters at right
angles (d1, d2) and the thickness (t) of
each tumour were made from 4 to 17 days
after implantation. The volume of each
tumour was calculated as v =-. (Td1d2t)/4.
Means and standard errors of the volumes
were used to construct the growth curve
(Fig. 2). The shape ofthe curve indicates
a reductioni ofgrowth rate with increasing
size: the volume doubling time increases
from .1 day for tumours of <60 mm3 to
-4 days for tumours -500mm3. The
slowing of growth rate is evident before
the tumour burden is large enough to
affect the mouse constitutionally and may
be due to an increased cell loss from the
surface of larger ulcerating tumours.
10
life " of 9-5 + 13-5 days and an " average
life" of 13-7 + 13-5 days.
(iii) A reciprocal time model (Porter,
1975, personal communication).-Another
reasonable description of the survival
data was obtained by plotting the
frequency of deaths against reciprocal
time-this yieldsanapproximatelynormal
unskewed distribution with a mean of
0-043 day-1 (- 234 days) and a s.d. of
0-016 day-' (X2 -- 8-57; d.f.4; P > 0.05).
Biologically, the reciprocal oftime may be
considered a measure ofthe rate of metas-
tatic evolution, and cured mice with an
infinitely slow rate of development of
metastases could be plotted at zero on the
reciprocal time scale. However, this
approach appears to offer no particular
advantage and the exponential survival
model provides a better description of
the data here presented.
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FIG. 2.-Growth curve (log volume V8 time)
of tumours resulting from intradermal
implants of 1-1 x 105 cells of WHT Sq.
Ca. " G ". Errors represent one s.e. mean
of the number of tumours indicated beside
each point.
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Section B
1. Relationship between size and
duration ofprimnary imnplant and the risk
of subsequent metastasis
Figure 3 is a scattergram of the
survival times of 306 mice as a function
of the size of their primary lesions at the
timeoflocal cure (allexcept 29byexcision).
From this scattergram, it can be seen that
the length ofsurvival ofmice which died of
metastases showed no relation to the size
of the primary implant, the majority of
metastatic deaths at all sizes occurring
10-40 days after treatment.
The probability of developing metas-
tases at all is related to some extent to the
size of the primary growth, but the
correlation is poor and is not statistically
significant in the 33-150 mm3 range
(corr. coeff. = 0-6; d.f.5; P w 0.2).
A similar analysis of the effect of
duration of primary growth on survival
and risk of metastasis is presented in
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Fig. 4. This indicates that within the
range 6-29 days, there is no relation
between period of growth and the risk of
metastasis (corr. coeff. -- 0-02; d.f.6;
P t 0.9).
2. Failure of volu.me-time integrals to
predict risk. of metastasis
As neither volume nor duration of
growth of the primary tumour implant
provided a satisfactory estimate of the
risk of developing metastasis, a test was
made to see if integral functions of the
two would be any better. Integrals were
derived in 2 ways depending on the
assumptions made as to the growth pat-
terns of the tumours (Fig. 5), but neither
yielded a better correlation with prognosis
than did size alone.
3. A threshold for metastUsis?
In an experiment to determine just
how early metastasis could be established
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FIG. 3.-Survival of mice in relation to the mean size of their primary implants at the time oflocally
curative treatment.
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FIG. 4.-Survival of:mice in relation to the duration of growth of their primary implants before
before locally curative treatment.
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Fio. 5.-Derivation of volume-time integrals. In both figures the solid line is the measured growth
curve from Fig. 2 plotted on linear coordinates. The dashed lines are theoretical growth curves of
tumours which took a longer or shorter time to reach a referencevolume (hereindicated as 100 mm3).
The volume-time integral is the area under the curve corresponding to the actual time to grow to
the reference volume (examples 6, 12 or 16 days).
In panel (a) the theoretical curves are drawn on the premise that the shape of the growth curve
has not varied but that the growth rates ofthe tumours are different. In panel (b) the assumption
is that there was variable delay in initiation of tumour growth, but that once established, all
tumours grew at the same rate. Integrals obtained in this way can be seen to be essentially
proportional to the reference volume.
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in the system, a groul) of 30 mice received
an implant of 105 cells intradermally.
The injection site was excised from groups
of 5 mice daily for 6 days. No mouse
whose tumour was excised on or before the
5th day after implantation, at a size of
,-10-20 mm3, succumbed to metastasis.
This appears to represent the threshold
of tumour exposure required to establish
distant metastases as tumour excision on
the 6th or subsequent days did not provide
complete protectionfrom metastaticdeath.
DISCUSSION
Section A
A knowledge of the distribution of
survival times of patients following
cancer therapy enables statistical projec-
tions of the cured proportion of patients
to be made. Boag (1948) presented
survival data from patients with cancer
of the mouth and throat and showed that
the distribution of deaths from cancer
was log-normal with respect to time.
The relative contributions of local recur-
rences and distant metastases to these
deaths is not given. Porter (1971)
analysed local recurrences of squanmous
carcinomata of the alveolus and floor of
mouth and found them inconsistent with a
log-normal distribution. Haybittle (1959)
also found the log-normal distribution
inadequate to describe the survival of
breast cancer patients. In addition, he
found the exponential model of survival
unsatisfactory, and presented an " extra-
polated actuarial " model in which the
probability of dying, for the whole
population at risk, decreased exponen-
tially with time. The analysis of human
survival data is complicated by such
factors as deaths from intercurrent dis-
ease; prolongation of survival by secon-
dary treatment, e.g. chemotherapy; errors
in recording the exact cause ofdeath; and
undeclared local recurrences. In the
experimental context, the first 3 of these
problems can be overcome completely and
the incidence of unsuspected local recur-
rences after excision of dermal tumours is
almost certainly negligible. Deaths from
metastatic cancer in this systemwere not
compatible with a log-normal distribution
(see Experiments and Results), but an
exponential model of survival with an
iiiitial " shoulder " provided a good des-
cription ofthe data (Fig. 1(b)).
The different survival patterns of ex-
perimental mice compared with alhuman
cancer population may simply be due to
the heterogeneity ofthe latter. A mixture
of several subpopulations, each with an
exponential survival, willtendtoproduce a
log-normal distribution of deaths and,
furthermore, the composite curve of
cancer deaths peryear for such subpopula-
tions will be concave upwards on a
semilog plot as is seen in Haybittle's
(1959) breast cancer data. Thus, it is
entirely plausible that the exponential
model correctly describes the survival of
homogeneous subpopulations of human
cancer patients, as it does for experi-
mental mice.
In the experiments reported here, the
median survival of doomed mice was
between 23 and 24 days. Frequently, at
death, the largest metastatic deposits
were about 5 mm diameter (,65 mm3).
Assuming that these metastatic lesions
grew from one cell, or a few cells, the
average survival time correlates with the
measured volume doubling time for
primary cutaneous implants of <-1 day
up to 65 mm3. However, the spread of
survival time is great, with several mice
surviving over 50 days. Indeed, one
mouse succumbed 168 days after excision
of its primary implant. This range of
survival in a homogeneous system where
" host resistance " is not a variable is
remarkable and indicates the presence of
random factors influencing the growth of
metastases. Translated into a clinical
context, one might suggest that if the
average survival for a particular cancer
was say 3 years, then occasional survivals
of 10-12 years could be expected without
invoking any variation of specific " host
resistance ".
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Section B
The principal determinant of meta-
static risk for a given tumour is
undoubtedly the biological balance
between the tumour and its host. The
purpose of the analysis reported here was
to try to identify the major elements of
metastatic risk when the tumour-host
relationship was kept constant by using a
single syngeneically transplanted tumour
line.
Neither the volume nor the duration
ofgrowth ofthe primary implant could be
shown to correlate significantly with the
risk of metastasis within the ranges
examined. Similarly, integral functions
of volume and time were unhelpful as
prognostic indicators.
Nonetheless, the experiment to test for
a threshold for metastasis showed that
tumours of 20 mm3 or less did not initiate
metastases, while only 1/39 mice bearing
tumours larger than 120 mm3 survived
long-term. It therefore appears that, as
with many human tumours, size of
primary growth is a crude index of
metastatic risk.
The failure to obtain significant corre-
lations of metastatic risk with size or
duration of primary growth in a homo-
geneous system is at first sight surprising.
However, these parameters cannot include
such considerations as the contribution of
non-viable tissue and stromal elements to
tumour volume, and perhaps it is only
those tumour cells lining blood and lymph
vessels which should be regarded as
contributing to the metastatic risk. The
exact placement of the tumour cell
inoculum is probably also of importance,
as radiation studies have indicated a
variation of hypoxic cell fraction accord-
ing to the transplantation site, which
probably reflects differences in vasculariz-
ation (Peters, 1974).
Finally, the notion of a threshold for
the establishment of metastasis deserves
comment. Why is it that tumours, both
clinical and experimental, show so much
variation in the time for which they
remain " localized "? There is abundant
evidence that it is not due to a failure of
dissemination of tumour cells into the
circulation but rather a failure of estab-
lishment of disseminated cells at remote
sites. Thisisoftenasserted to beevidence
of immune host resistance, but even in
non-immunogenic tumour systems the
great majority of cells entering the circu-
lation fail to survive (Hewitt and Blake,
1975). The mechanism responsible for
this nonspecific killing or dying of cancer
cells is unknown, but it is possible to
accommodate the idea of a variable
metastasis threshold in terms of the
relative effectiveness of such a mechanism
for different tumours.
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